India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
This aims to benefit approximately 4.5 crore families with six crore senior citizens with Rs. 5 lakh free health insurance cover on a family basis
The publication serves as a foundational tool for identifying gaps and addressing needs in various areas, including rural, urban, and tribal regions
The recent inspection covered both cGMP and PAI processes
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Effective, holistic, science-backed targeted solutions for symptomatic treatment
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
Subscribe To Our Newsletter & Stay Updated
